|
|
Other links at Articles > Business of Medicine |
| 3. |
APP Raising Heparin Prices Amid Higher Costs
|
|
|
APP Pharmaceuticals Inc, the main supplier of the blood thinner heparin to the U.S. market in the wake of a contamination scandal, said on Thursday it was raising prices because of higher costs for raw materials, additional testing and labor. Reuters Health Information
|
| 4. |
What Broke Me
|
|
|
On a medical mission to an impoverished country, a medical student experiences the human toll of healthcare disparities.
Medscape Med Students
|
| 5. |
Intensive-Glycemic-Control Arm of ACCORD Stopped
|
|
|
The blood-glucose-lowering part of the ACCORD trial in patients with type 2 diabetes at especially high risk of heart disease has been stopped prematurely because of a higher rate of mortality in the patients in the intensive arm vs that in the standard arm. Heartwire
|
|
|
